These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20886091)

  • 1. Nondenaturing purification of co-transcriptionally folded RNA avoids common folding heterogeneity.
    Pereira MJ; Behera V; Walter NG
    PLoS One; 2010 Sep; 5(9):e12953. PubMed ID: 20886091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of flanking regions on HDV cotranscriptional folding kinetics.
    Wang Y; Wang Z; Liu T; Gong S; Zhang W
    RNA; 2018 Sep; 24(9):1229-1240. PubMed ID: 29954950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The folding pathway of the genomic hepatitis delta virus ribozyme is dominated by slow folding of the pseudoknots.
    Chadalavada DM; Senchak SE; Bevilacqua PC
    J Mol Biol; 2002 Apr; 317(4):559-75. PubMed ID: 11955009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nested double pseudoknot is required for self-cleavage activity of both the genomic and antigenomic hepatitis delta virus ribozymes.
    Wadkins TS; Perrotta AT; Ferré-D'Amaré AR; Doudna JA; Been MD
    RNA; 1999 Jun; 5(6):720-7. PubMed ID: 10376872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic partitioning mechanism of HDV ribozyme folding.
    Chen J; Gong S; Wang Y; Zhang W
    J Chem Phys; 2014 Jan; 140(2):025102. PubMed ID: 24437918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparate HDV ribozyme crystal structures represent intermediates on a rugged free-energy landscape.
    Sripathi KN; Tay WW; Banáš P; Otyepka M; Šponer J; Walter NG
    RNA; 2014 Jul; 20(7):1112-28. PubMed ID: 24854621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic analysis of the hepatitis delta virus (HDV) ribozyme: methods for RNA preparation, structure mapping, solvent isotope effects, and co-transcriptional cleavage.
    Chadalavada DM; Cerrone-Szakal AL; Wilcox JL; Siegfried NA; Bevilacqua PC
    Methods Mol Biol; 2012; 848():21-40. PubMed ID: 22315061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mechanistic framework for co-transcriptional folding of the HDV genomic ribozyme in the presence of downstream sequence.
    Diegelman-Parente A; Bevilacqua PC
    J Mol Biol; 2002 Nov; 324(1):1-16. PubMed ID: 12421555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terbium-mediated footprinting probes a catalytic conformational switch in the antigenomic hepatitis delta virus ribozyme.
    Harris DA; Tinsley RA; Walter NG
    J Mol Biol; 2004 Aug; 341(2):389-403. PubMed ID: 15276831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic characterization of the HDV genomic ribozyme: the cleavage site base pair plays a structural role in facilitating catalysis.
    Cerrone-Szakal AL; Chadalavada DM; Golden BL; Bevilacqua PC
    RNA; 2008 Sep; 14(9):1746-60. PubMed ID: 18658121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse RNA Folding Workflow to Design and Test Ribozymes that Include Pseudoknots.
    Kayedkhordeh M; Yamagami R; Bevilacqua PC; Mathews DH
    Methods Mol Biol; 2021; 2167():113-143. PubMed ID: 32712918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pseudoknot ribozyme structure is active in vivo and required for hepatitis delta virus RNA replication.
    Jeng KS; Daniel A; Lai MM
    J Virol; 1996 Apr; 70(4):2403-10. PubMed ID: 8642668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of a highly reactive HDV ribozyme sequence uncovers facilitation of RNA folding by alternative pairings and physiological ionic strength.
    Brown TS; Chadalavada DM; Bevilacqua PC
    J Mol Biol; 2004 Aug; 341(3):695-712. PubMed ID: 15288780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential folding of the genomic ribozyme of the hepatitis delta virus: structural analysis of RNA transcription intermediates.
    Matysiak M; Wrzesinski J; Ciesiołka J
    J Mol Biol; 1999 Aug; 291(2):283-94. PubMed ID: 10438621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro selection analysis of trans-acting HDV ribozyme.
    Nishikawa F; Chiba A; Shirai M; Fauzi H; Taira K; Kumar PK; Nishikawa S
    Nucleic Acids Symp Ser; 1995; (34):115-6. PubMed ID: 8841579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A three-dimensional model of hepatitis delta virus ribozyme based on biochemical and mutational analyses.
    Tanner NK; Schaff S; Thill G; Petit-Koskas E; Crain-Denoyelle AM; Westhof E
    Curr Biol; 1994 Jun; 4(6):488-98. PubMed ID: 7922369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of Lp3 enlargement on the folding and catalysis of hepatitis delta virus cis-cleaving ribozyme.
    Wu HN; Lee JY; Ping YH; Wang CN
    FEBS Lett; 1998 Nov; 439(3):312-6. PubMed ID: 9845344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant kinetic solvent isotope effects in folding of the catalytic RNA from the hepatitis delta virus.
    Tinsley RA; Harris DA; Walter NG
    J Am Chem Soc; 2003 Nov; 125(46):13972-3. PubMed ID: 14611229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic strategies of the hepatitis delta virus ribozymes.
    Shih IH; Been MD
    Annu Rev Biochem; 2002; 71():887-917. PubMed ID: 12045114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic Parameters of trans Scission by Extended HDV-like Ribozymes and the Prospect for the Discovery of Genomic trans-Cleaving RNAs.
    Webb CT; Lupták A
    Biochemistry; 2018 Mar; 57(9):1440-1450. PubMed ID: 29388767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.